Dawn Faller/Linkedin
Apr 24, 2026, 17:35
Dawn Faller: Strengthening Global Collaboration in Apheresis at the 2026 ASFA and WAA Joint Meeting
Dawn Faller, Sr. Manager of Global Clinical Marketing at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
”Today we had the opportunity to welcome attendees of the 2026 ASFA and WAA Joint Meeting to the Terumo Blood and Cell Technologies Campus Headquarters ahead of the meeting kickoff.
This tour was a great opportunity to showcase the people and technologies behind our work.
It also highlighted how our teams at Terumo Blood and Cell Technologies are working alongside partners across the field to advance apheresis and help ensure blood remains an essential therapy for patients worldwide.
Looking forward to continuing these conversations throughout the conference.”
Stay updated with Hemostasis Today.
-
Apr 24, 2026, 17:58Erwin Loh: Triple Combination Therapy Shows Major Benefit in Preventing Recurrent Stroke
-
Apr 24, 2026, 17:51Mostafa Faisal Mohammed Saleh: Exploring the Impact of PNH Clones in Aplastic Anemia Across Different Treatment Strategies
-
Apr 24, 2026, 17:30Omar Adwan: Easy-to-Remember Tips for MCV
-
Apr 24, 2026, 17:07Melissa Hollo: Revolutionizing Diagnostics Through Real-Time Anemia Management at Executive War College
-
Apr 24, 2026, 17:03Oscar William-Donkor: Faith, Blood and Choice
-
Apr 24, 2026, 17:01Julie Rayes: Presenting Our Data at the 12th Symposium on Hemostasis
-
Apr 24, 2026, 16:56Nazish Saqlain: Hands-on Training Workshop in Transfusion Medicine and Immunohematology
-
Apr 24, 2026, 16:49Michael Greger: Most Heart Attacks Are Triggered by Non-Obstructive Plaques
-
Apr 24, 2026, 16:06Maxime Dely: Venous Access in Apheresis Technology Isn’t Everything